Importantly, the reduction in lipid levels in tumors by semaglutide combined with the inhibition of de novo lipid synthesis via the Insig1/2 loop 1 peptide produced an additive tumor‐inhibiting effect and prolonged mouse survival. The gene discussed is INSIG1; the disease is neoplasm.